Guest Column | October 1, 2015

U.K. Approval Of Informed Electronic Consent: A Pivotal Moment In Enhancing Trial Enrollment

U.K. Approval Of Informed Electronic Consent: A Pivotal Moment In Enhancing Trial Enrollment

By Stuart McCully, VP, inVentiv Health Clinical

The recent approval by Britain’s National Health Service (NHS) for the use of electronic informed consent in a clinical trial is a pivotal moment in the global expansion of a technology that benefits both patients and sponsors of clinical research.

Approval for the use of electronic informed consent from the California-based company, Mytrus, was granted by the Health Research Authority (HRA), a division of Britain’s NHS, established to promote and protect the interests of patients participating in research.  HRA oversees research ethics committees in England, as well as innovation in research, and the agency is interested in how eConsent technology impacts both trial efficiency and the ethical treatment of patients.  

VIEW THE GUEST COLUMN!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: